Administered Prices: Hearings, Eighty-fifth Congress, First Session Pursuant to S. Res. 56U.S. Government Printing Office, 1957 - 232 páginas |
Dentro del libro
Resultados 1-3 de 100
Página 15607
... products embodying or made in accordance with the same shall be deemed to be Licensed Products . LICENSEE hereby agrees to disclose promptly to ... LICENSEE with respect to Licensed Products , and the royalties ADMINISTERED PRICES 15607.
... products embodying or made in accordance with the same shall be deemed to be Licensed Products . LICENSEE hereby agrees to disclose promptly to ... LICENSEE with respect to Licensed Products , and the royalties ADMINISTERED PRICES 15607.
Página 15765
... product is chemically identical to a Licensed Product A ( or to a thera- peutically active ingredient thereof which causes the product to be a Licensed Product A ) but such product is nevertheless con- sidered by BRISTOL to be ...
... product is chemically identical to a Licensed Product A ( or to a thera- peutically active ingredient thereof which causes the product to be a Licensed Product A ) but such product is nevertheless con- sidered by BRISTOL to be ...
Página 15784
... Licensed Products A and Licensed Products B or undertake to indemnify LICENSEE , its directors , officers , employees and agents against any and all damages , costs and expenses that any one or more of them may incur or become liable to ...
... Licensed Products A and Licensed Products B or undertake to indemnify LICENSEE , its directors , officers , employees and agents against any and all damages , costs and expenses that any one or more of them may incur or become liable to ...
Contenido
Page | 15331 |
Foreign license agreements of Bristol Laboratories and related | 15458 |
ExhibitsContinued | 15726 |
Otras 22 secciones no mostradas
Otras ediciones - Ver todas
Términos y frases comunes
added to Schedule Allen & Hanburys amended America American Cyanamid Company and/or annexed hereto antibiotic substance aplastic anemia Application being filed Article FOURTH BRISTOL hereby BRISTOL LABORATORIES INC chloramphenicol Chloromycetin Chlortetracycline commensurate to pending confidential know-how corporation organized cycline DAVIS & COMPANY deemed to mean drug duly authorized effect fermentation filed commensurate Filing Date hereby agrees hereinafter defined hereinafter referred HOECHST Issue Date January July laws LEPETIT letter license agreement Licensed Cyanamid Patents Licensed Patents Licensed Products Finished LICENSEE LICENSEE'S Licensor manufacture organized and existing Paragraph Parke Davis Parke-Davis parties hereto Patent Applications Serial patent rights payable pending United penicillin Pfizer priority date priority date thereof products containing pursuant respect retailers rights and licenses royalties sales of Licensed Sales Price secret formulae secret processes sublicense subsidiaries or affiliates Supplemental Agreement termination Territory Tetracycline therapeutically active ingredients third party trade trademarks United States dollars United States Patent WHEREAS York